Xavier Blanco Email Address

OPKO Health, Inc. (OPKO) is a healthcare company. The Company operates through two segments: diagnostics and pharmaceutical. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, and its pharmaceutical research and development operations. The diagnostics segment primarily consists of its clinical laboratory operations. The Company's diagnostics business includes Bio-Reference Laboratories (Bio-Reference), which is a clinical laboratory with a genetic testing business, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. Its pharmaceutical business includes OPKO Biologics, which features hGH-CTP, a once-weekly human growth hormone injection (in Phase III and partnered with Pfizer), and a longer acting Factor VIIa drug for hemophilia (Phase IIa). In addition to its pharmaceutical and diagnostic development programs, it owns pharmaceutical platforms in Ireland, Chile, Spain and Mexico.

Financial reporting manager with record of improving bottom-line results through cost controls, increased operational efficiency and process enhancements. Skilled decision-maker who is both focused and highly effective at multi-tasking in a dynamic fast paced environment. A proven problem-solver with an ability to proactively identify business issues, develop and implement effective solutions. Specialties: • Finance and Accounting • Budget & Forecasting • Cash Flow Management • Receivables & Collections • Financial Reporting & Analysis • Evaluation, Development & Implementation of Internal Controls • Systems Implementation • Profit Improvement, Cost Management & Reduction • Languages: English and Spanish.